QUalification of Efficacy in the study of intENsive care with Tolvapta
Not Applicable
- Conditions
- Congestive heart failure patients
- Registration Number
- JPRN-UMIN000007037
- Lead Sponsor
- Division of Cardiovascular Medicine , Department of Internal Medicine,Kobe University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 54
Inclusion Criteria
Not provided
Exclusion Criteria
1.Acute myocardial infarction 2.Patients with circulatory assist device 3.Severe hypotension or cardiogenic shock 4.Patients are considered undesirable rapid decrease in blood flow circulation 5.Patients with right heart ventricular infarction 6.Activ form of myocarditis 7.Patients with dehydration 8.Total bilirubin>3.0mg/dL 9.Serum K>5.5mEq/L 10.Serum K>5.5mEq/L 11.Patietns with hypersensitivity to study drug 12.Anuric patients 13.Insensitivity to the thirst or difficult for the water intake 14.Hypernatremia (serum Na>147mEq/L) 15.Pregnant woman, lactational woman, patients may be willing to be pregnant or are pregnant 16.In addition, patients were judged as inadequate by physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method